A Case report of response to crizotinib in a squamous cell lung carcinoma patie
PUBLISHED: 2015-11-26  306 total views, 3 today

Wenxian Wang 

Department of Thoracic oncology, Zhejiang Cancer Hospital, Hangzhou.


Objective: Wepresent a case of ALK gene translocation-squamous cell lung cancer whichexperienced a remarkable tumor response to crizotinib after failure of priorchemoradiotherapy. Method: A case report response to crizotinib in asquamous cell lung carcinoma patient harbouring EML4-ALK translocation. Result:We present a case of ALK gene translocation-squamous cell lung cancer whichexperienced a remarkable tumor response to crizotinib after failure of priorchemoradiotherapy. Conclusion: Considering this remarkable response, weconclude that ALK test in SCC is recommended in non-smoker patient ornon-responder to initial regimen of chemotherapy.


Key Words: EML4 ALK Crizotinib  Squamous cell lungcancer

 


Copyright © 1998 - 2018 Chinese Society of Clinical Oncology(CSCO). All Rights Reserved

京公网安备 11010502031031号

Contact Us

EMAIL:office@csco.org.cn

international@csco.org.cn

Phone:86(10)67726451 (Beijing)

86(25)84547290 (Nanjing)